Primary and secondary cardiovascular prevention: Recent advances

Area of Science:

• Cardiology
• Preventive Medicine
• Public Health

Background:

• Cardiovascular disease (CVD) is a major global health issue, causing 20 million deaths annually.
• Current risk prediction models may be limited by focusing solely on individuals over 40 and short-term (10-year) predictions.
• The distinction between primary and secondary prevention warrants re-evaluation, considering atherosclerosis as a continuous process.

Purpose of the Study:

• To review the latest advancements in cardiovascular disease (CVD) diagnosis and prevention strategies.
• To explore the integration of novel therapeutic agents and digital health tools in CVD management.
• To assess the potential of updated prevention strategies in reducing the global burden of CVD.

Main Methods:

• Literature review of recent developments in CVD prevention.
• Analysis of pharmacological treatments, technological innovations, and lifestyle modifications.
• Examination of novel agents and digital health tools for patient adherence and outcomes.

Main Results:

• Significant advancements in pharmacological treatments and lifestyle interventions (diet, physical activity, sleep, smoking cessation) are crucial for coronary artery disease prevention.
• Novel agents and digital health tools show promise in improving long-term patient adherence and clinical outcomes.
• Integrating these advancements can enhance the effectiveness of both primary and secondary CVD prevention.

Conclusions:

• The evolving landscape of CVD prevention necessitates a broader approach, considering atherosclerosis as a continuous process.
• Novel therapeutic agents and digital health technologies are key to improving patient outcomes and adherence.
• Enhanced integration of these strategies into clinical practice is vital for reducing the global burden of cardiovascular disease.